日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors

针对 ADAM9 表达肿瘤的下一代美登木素抗体药物偶联物 IMGC936 的临床前评估

Juniper A Scribner #, Stuart W Hicks #, Kerstin W Sinkevicius, Nicholas C Yoder, Gundo Diedrich, Jennifer G Brown, Jacquelynn Lucas, Megan E Fuller, Thomas Son, Anahita Dastur, Jeff Hooley, Christopher Espelin, Marian Themeles, Francine Z Chen, Ying Li, Michael Chiechi, Jenny Lee, Bhaswati Barat, Lu

A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells

靶向 CD123 的抗体-药物偶联物 IMGN632 旨在根除 AML,同时保留正常骨髓细胞

Yelena Kovtun, Gregory E Jones, Sharlene Adams, Lauren Harvey, Charlene A Audette, Alan Wilhelm, Chen Bai, Lingyun Rui, Rassol Laleau, Fenghua Liu, Olga Ab, Yulius Setiady, Nicholas C Yoder, Victor S Goldmacher, Ravi V J Chari, Jan Pinkas, Thomas Chittenden

Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates

作为美登木素抗体-药物偶联物的抗体库的微尺度筛选

Kalli C Catcott, Molly A McShea, Carl Uli Bialucha, Kathy L Miller, Stuart W Hicks, Parmita Saxena, Thomas G Gesner, Mikias Woldegiorgis, Megan E Lewis, Chen Bai, Michael S Fleming, Seth A Ettenberg, Hans K Erickson, Nicholas C Yoder

Use of fungal derived polysaccharide-conjugated particles to probe Dectin-1 responses in innate immunity

使用真菌衍生的多糖结合颗粒探测先天免疫中的 Dectin-1 反应

Jenny M Tam, Michael K Mansour, Nida S Khan, Nicholas C Yoder, Jatin M Vyas